Rockefeller Capital Management L.P. Biocryst Pharmaceuticals Inc Transaction History

Rockefeller Capital Management L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.89 - $17.88 $220 - $500	-28 Reduced 0.73%	3,800 $40,000
Q1 2022 May 13, 2022	BUY	$11.56 - $19.76 $323 - $553	28 Added 0.74%	3,828 $62,000
Q1 2021 May 11, 2021	BUY	$7.37 - $13.61 $3,685 - $6,805	500 Added 15.15%	3,800 $38,000
Q1 2020 May 12, 2020	BUY	$1.6 - $4.11 $5,280 - $13,563	3,300 New	3,300 $7,000

260

173M

397K

444K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.43B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.